Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$1.3B
Avg Funding
$52.3M
Global Reach
8
countries

Top Cities for Biopharma

Zug
Woburn
San Francisco
Berwyn
Mclean
Warsaw

Recently Funded Companies

Export
Zug, Switzerland

Quercis Pharma is a biopharmaceutical company that brings innovative and safe medicine to patients with orphan diseases.

$150.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Woburn, United States

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

$110.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

$287.5M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Berwyn, United States

Virpax is developing differentiated treatment options that address unmet needs in three multi-billion-dollar markets

$6.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Mclean, United States

KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.

$6.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Warsaw, Poland

ExploRNA Therapeutics creates revolutionary advancements using mRNA as a therapeutic platform.

$814K raised
Dec 2022

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

$53.0M raised
Dec 2021

Founder Contacts

30,000+ verified contacts

Berkeley, United States

Innovative Genomics Institute uses genome editing to develop accessible solutions in human health, climate, and agriculture.

Jan 2026

Founder Contacts

30,000+ verified contacts

Austin, United States

Aether Therapeutics is a biotechnology compound that develops pharmaceutical compound to treat addiction and withdrawal symptoms.

$210K raised
Dec 2024

Founder Contacts

30,000+ verified contacts

Raleigh, United States

Traitology is engaged in the development of novel traits in soybean and other key crops of global importance.

$25.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Woburn, United States

100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.

$20K raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Bozeman, United States

PurCell Bio is a biotechnology company that offers cell culture services.

$841K raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Rockville, United States

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

$53.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Kyoto, Japan

XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.

$6.1M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Rosario, Argentina

Dharma Bioscience is a biotech company that develops biomedical solutions to facilitate tissue regeneration without the need for surgery.

Dec 2024

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.

$150.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Bukit Merah, Singapore

GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.

$21.0M raised
Jan 2024

Founder Contacts

30,000+ verified contacts

Stamford, United States

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

$275.0M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

San Carlos, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

$2.8M raised
Jan 2023

Founder Contacts

30,000+ verified contacts

Menlo Park, United States

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

$15.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Lexington, United States

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

$120.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

Indianapolis, United States

PinkDx is a biotechnology company.

$5.0M raised
Jan 2025

Founder Contacts

30,000+ verified contacts

Dublin, Ireland

Beyondbmi is a digital medical obesity care pathway

$1.1M raised
Dec 2023

Founder Contacts

30,000+ verified contacts

New York, United States

Intelligent Bio Solutions leverages the power of technology to develop transformative, accurate solutions that improve quality of life.

$10.0M raised
Dec 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

$10.0M raised
Dec 2022

Founder Contacts

30,000+ verified contacts

Showing 626 to 650 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$52.3M
Total Funding Tracked
$1.3B
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Woburn
2 companies$110.0M
2.San Francisco
2 companies$297.5M
3.Zug
1 companies$150.0M
4.Berwyn
1 companies$6.0M
5.Mclean
1 companies$6.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

854 Biopharma Startups (2026) — Recently Funded Companies, Investors & Rounds — Page 26 | VCBacked